Preprint Case Report Version 1 Preserved in Portico This version is not peer-reviewed

Intrahepatic Cholangiocarcinoma and Acute Intermittent Porphyria: A Case Report

Version 1 : Received: 31 March 2023 / Approved: 4 April 2023 / Online: 4 April 2023 (04:53:33 CEST)

A peer-reviewed article of this Preprint also exists.

Guida, C.C.; Nardella, M.; Fiorentino, L.; Latiano, T.; Napolitano, F.; Ferrara, G.; Crisetti, A.; Mazzoccoli, G.; Aucella, F.; Aucella, F. Intrahepatic Cholangiocarcinoma and Acute Intermittent Porphyria: A Case Report. J. Clin. Med. 2023, 12, 3091. Guida, C.C.; Nardella, M.; Fiorentino, L.; Latiano, T.; Napolitano, F.; Ferrara, G.; Crisetti, A.; Mazzoccoli, G.; Aucella, F.; Aucella, F. Intrahepatic Cholangiocarcinoma and Acute Intermittent Porphyria: A Case Report. J. Clin. Med. 2023, 12, 3091.

Abstract

Porphyrias are human metabolic diseases characterized by different modes of inheritance and clinical manifestations and caused by deficiency of enzymes of the heme biosynthetic pathway. The forms of porphyria are characterized by elevated levels of δ-aminolevulinic acid and porphobilinogen. Acute hepatic porphyrias are a subgroup of porphyrias characterized by the appearance of neurovisceral attacks with or without cutaneous signs. Acute hepatic porphyrias include four diseases: acute intermittent porphyria, variegate porphyria, hereditary coproporphyria, and hereditary δ-aminolevulinic acid dehydratase deficiency. These enzymatic deficiencies cause a harmful accumulation of porphyrins in the liver and bone marrow that trigger a wide range of signs and symptoms. Patients suffering from different forms of acute hepatic porphyria present a high risk of liver cancer, precisely hepatocellular carcinoma and cholangiocarcinoma, determined by the activity of the disease even though an exact mechanism of carcinogenesis has not been recognized yet. Here, we present the clinical case of a 72 year old woman who, approximately 29 years after the diagnosis of acute intermittent porphyria, presented with intrahepatic cholangiocarcinoma with histological diagnosis of adenocarcinoma starting from the biliary-pancreatic ducts, which was diagnosed during the clinical and anatomopathological evaluation of a pathological fracture of the femur.

Keywords

acute hepatic porphyria; cholangiocarcinoma; delta aminolevulinic acid; porphobilinogen; hydroxymethylbilane synthase

Subject

Biology and Life Sciences, Life Sciences

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.